Kim Kelderman, President Diagnostics & Genom at BIO-TECHNE Corp (TECH), sold 1,646 shares at $388.45 ($639K) on 2021-02-05, disclosed to the SEC on 2021-02-09.
Open-market sale of $639k TECH by President Diagnostics & Genom. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $388.45 | 823 | $320K | 50.0% |
| 2 | $388.45 | 823 | $320K | 50.0% |
| Total | $388.45 avg | 1,646 | $639K | 100% |
| Filing → |
| TECH | SELL | 2021-09-24 | $870K | — | Filing → |
| TECH | SELL | 2021-06-11 | $351K | — | Filing → |
| TECH | SELL | 2021-05-27 | $358K | — | Filing → |